Skip to main
NAVB
NAVB logo

Navidea Biopharma (NAVB) Earnings Dates & Reports

Navidea Biopharma (NAVB) Most Recent Earnings

Report Date
Period EndingQ3 2021
Est. EPS-$0.11
Actual EPS-$0.08
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Navidea Biopharma (NAVB) Earnings per Share (EPS) History

Signup for full access
Browse free

Navidea Biopharma (NAVB) Latest Earnings

The value each NAVB share was expected to gain vs. the value each share gained.

Navidea Biopharma (NAVB) reported its most recent earnings on for Q3 2021, posting earnings per share (EPS) of -$0.08. This exceeded analysts' expectations of -$0.11 by 27.27%, marking a Beat.

For comparison, Navidea Biopharma reported EPS of -$0.13 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

Navidea Biopharma (NAVB) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2023
-$0.02
DeckReportListen
Q2 2023
-$0.03
DeckReportListen
Q1 2023
-$0.09
DeckReportListen
Q4 2022
-$0.11
DeckReportListen
Q3 2022
-$0.25
DeckReportListen
View all

Navidea Biopharma (NAVB) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Navidea Biopharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Navidea Biopharma (NAVB) Earnings FAQs

Navidea Biopharma (NAVB) last reported earnings on Nov 10, 2021 for Q3 2021, posting an EPS of -$0.08, which Beat the estimate of -$0.11 by 27.27%.

For Q3 2021, Navidea Biopharma (NAVB) reported an EPS of -$0.08, exceeding analysts' estimate of -$0.11 by 27.27%.

For Q3 2021, Navidea Biopharma (NAVB) Beat expectations with an actual EPS of -$0.08 vs. an estimated EPS of -$0.11.

Following the last earnings report on Nov 10, 2021, Navidea Biopharma (NAVB)'s stock price moved — from — to —.

The next Navidea Biopharma (NAVB) earnings call is scheduled for Nov. 14, 2023, where executives will discuss financial results and outlook.

Navidea Biopharma (NAVB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.